Contact Us

+350 20079000 info@hassans.gi

This data will only be used by Hassans for processing your query and for no other purpose. View our privacy policy

Time to pay attention to Psychedelic Medicine says The Motley Fool

As previously highlighted in other posts, investors should keep an eye out for stocks in the psychedelic medicine space. Mind Medecine, Compass Pathways and Field Trip Ventures are all candidates to go public in the next 12 months. 

Are we with psychedelic medicine where we were with cannabis 10-15 years ago?

What's important to understand is that a paradigm shift is starting to taking shape within the Western medical community. In effect, scientists are increasingly intrigued by the therapeutic potential of psychedelics as treatments for a whole range of mental health disorders. Pyschedelic medicine thus has the potential to be a gold mine for early investors. www.fool.com/...

Hassans advises DA Global on obtaining DLT Provider authorisation from the GFSC.

Hassans is pleased to announce that it has advised DA Global Limited (“DA Global”), a subsidiary of ARQ Group, on obtaining a Part 7...

Posted on
Read more

Latest Insights

Supreme Court Orders £8.2 Million Payment from Former Insurance CEO.

The Supreme Court of Gibraltar has delivered a significant result for the liquidators of a failed insurance company. Over two hearings on...

Posted on
Read more

How sweet it is to be loved by EU – but is reconciliation viable for the UK ?

Michel Barnier's warning that there is no "single market à la carte" will strike some as a familiar refrain. It is also correct. Ahead of...

Posted on
Read more

Hassans advises DA Global on obtaining DLT Provider authorisation from the GFSC.

Hassans is pleased to announce that it has advised DA Global Limited (“DA Global”), a subsidiary of ARQ Group, on obtaining a Part 7...

Posted on
Read more